Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MRNA |
---|---|---|
09:32 ET | 106491 | 131.545 |
09:34 ET | 59260 | 132 |
09:36 ET | 103181 | 129.83 |
09:38 ET | 65094 | 130 |
09:39 ET | 56461 | 129.265 |
09:41 ET | 121682 | 127.72 |
09:43 ET | 33372 | 128.3188 |
09:45 ET | 85412 | 128.51 |
09:48 ET | 67604 | 127.93 |
09:50 ET | 127914 | 126.65 |
09:52 ET | 99801 | 128.58 |
09:54 ET | 49926 | 128.61 |
09:56 ET | 43994 | 128.96 |
09:57 ET | 25198 | 128.91 |
09:59 ET | 33056 | 129.47 |
10:01 ET | 20824 | 129.6023 |
10:03 ET | 34665 | 129.215 |
10:06 ET | 46164 | 129.765 |
10:08 ET | 16199 | 129.71 |
10:10 ET | 11069 | 129.52 |
10:12 ET | 15101 | 129.5 |
10:14 ET | 25726 | 129.83 |
10:15 ET | 24889 | 130.915 |
10:17 ET | 42534 | 131.4195 |
10:19 ET | 14331 | 131.02 |
10:21 ET | 15027 | 130.15 |
10:24 ET | 4100 | 130.03 |
10:26 ET | 13967 | 130.57 |
10:28 ET | 13645 | 130.89 |
10:30 ET | 4890 | 131.01 |
10:32 ET | 5965 | 131.51 |
10:33 ET | 122583 | 130.74 |
10:35 ET | 12119 | 131.04 |
10:37 ET | 22864 | 130.28 |
10:39 ET | 32183 | 130.225 |
10:42 ET | 11567 | 129.465 |
10:44 ET | 6348 | 129.7701 |
10:46 ET | 13610 | 130.58 |
10:48 ET | 5524 | 130.57 |
10:50 ET | 11355 | 130.01 |
10:51 ET | 6266 | 130.5 |
10:53 ET | 8256 | 130.225 |
10:55 ET | 8300 | 130.58 |
10:57 ET | 33812 | 130.875 |
11:00 ET | 6108 | 130.87 |
11:02 ET | 7097 | 130.96 |
11:04 ET | 9093 | 131.69 |
11:06 ET | 35868 | 132 |
11:08 ET | 8150 | 131.385 |
11:09 ET | 5400 | 131.21 |
11:11 ET | 9171 | 131.16 |
11:13 ET | 33406 | 130.76 |
11:15 ET | 15539 | 130.515 |
11:18 ET | 6933 | 130.75 |
11:20 ET | 7158 | 130.42 |
11:22 ET | 3179 | 130.6332 |
11:24 ET | 15988 | 130.9 |
11:26 ET | 8077 | 131.06 |
11:27 ET | 11976 | 130.85 |
11:29 ET | 3300 | 130.77 |
11:31 ET | 7774 | 130.86 |
11:33 ET | 7921 | 130.37 |
11:36 ET | 2685 | 130.705 |
11:38 ET | 3806 | 130.73 |
11:40 ET | 1775 | 130.67 |
11:42 ET | 10192 | 130.405 |
11:44 ET | 4646 | 130.42 |
11:45 ET | 5221 | 130.654 |
11:47 ET | 13112 | 130.35 |
11:49 ET | 15448 | 130.595 |
11:51 ET | 25583 | 130.4012 |
11:54 ET | 3910 | 130.4 |
11:56 ET | 5963 | 130.275 |
11:58 ET | 17276 | 130.27 |
12:00 ET | 6133 | 130.2 |
12:02 ET | 18380 | 130.445 |
12:03 ET | 2845 | 130.45 |
12:05 ET | 8042 | 130.17 |
12:07 ET | 6868 | 130.06 |
12:09 ET | 24637 | 129.93 |
12:12 ET | 8118 | 129.43 |
12:14 ET | 26663 | 128.9703 |
12:16 ET | 20773 | 129.02 |
12:18 ET | 12489 | 128.97 |
12:20 ET | 20192 | 129.07 |
12:21 ET | 3567 | 129.0717 |
12:23 ET | 4117 | 129.34 |
12:25 ET | 3989 | 129.4 |
12:27 ET | 6597 | 129.515 |
12:30 ET | 7553 | 129.555 |
12:32 ET | 8781 | 129.35 |
12:34 ET | 8348 | 129.39 |
12:36 ET | 4331 | 129.1643 |
12:38 ET | 18097 | 129.085 |
12:39 ET | 18460 | 129.08 |
12:41 ET | 6378 | 128.9 |
12:43 ET | 27027 | 128.28 |
12:45 ET | 30315 | 127.63 |
12:48 ET | 56631 | 127.605 |
12:50 ET | 25568 | 127.255 |
12:52 ET | 23215 | 127.705 |
12:54 ET | 22003 | 127.91 |
12:56 ET | 3952 | 127.99 |
12:57 ET | 5722 | 127.935 |
12:59 ET | 11129 | 127.735 |
01:01 ET | 5754 | 127.38 |
01:03 ET | 27493 | 127.01 |
01:06 ET | 17611 | 126.65 |
01:08 ET | 16217 | 126.64 |
01:10 ET | 46102 | 126.56 |
01:12 ET | 21704 | 126.29 |
01:14 ET | 39334 | 125.88 |
01:15 ET | 32954 | 125.78 |
01:17 ET | 62732 | 125.305 |
01:19 ET | 55183 | 124.75 |
01:21 ET | 21176 | 125.11 |
01:24 ET | 20599 | 125.395 |
01:26 ET | 27158 | 125.415 |
01:28 ET | 19134 | 125.1 |
01:30 ET | 44181 | 125.18 |
01:32 ET | 38043 | 124.6423 |
01:33 ET | 18017 | 124.485 |
01:35 ET | 29414 | 124.79 |
01:37 ET | 29716 | 124.6999 |
01:39 ET | 40896 | 124.27 |
01:42 ET | 48775 | 124.09 |
01:44 ET | 29092 | 123.645 |
01:46 ET | 25888 | 124.02 |
01:48 ET | 49792 | 123.65 |
01:50 ET | 52117 | 122.96 |
01:51 ET | 40132 | 122.88 |
01:53 ET | 57160 | 122.615 |
01:55 ET | 40223 | 122.47 |
01:57 ET | 45888 | 123.0575 |
02:00 ET | 46178 | 123.76 |
02:02 ET | 34812 | 123.23 |
02:04 ET | 28168 | 123.16 |
02:06 ET | 16856 | 123.0966 |
02:08 ET | 21368 | 123.43 |
02:09 ET | 18210 | 123.81 |
02:11 ET | 52166 | 124.2999 |
02:13 ET | 42083 | 125.02 |
02:15 ET | 55177 | 125.85 |
02:18 ET | 39851 | 125.55 |
02:20 ET | 10913 | 125.6 |
02:22 ET | 37741 | 125.3497 |
02:24 ET | 36243 | 125.235 |
02:26 ET | 14697 | 125.715 |
02:27 ET | 30468 | 126.09 |
02:29 ET | 16348 | 125.06 |
02:31 ET | 7260 | 125.26 |
02:33 ET | 15179 | 125.255 |
02:36 ET | 10535 | 125.7 |
02:38 ET | 26492 | 125.78 |
02:40 ET | 6235 | 126.02 |
02:42 ET | 10964 | 125.755 |
02:44 ET | 6499 | 125.475 |
02:45 ET | 7905 | 125.635 |
02:47 ET | 14488 | 125.39 |
02:49 ET | 14083 | 125.66 |
02:51 ET | 18327 | 124.7 |
02:54 ET | 15455 | 124.855 |
02:56 ET | 14237 | 125.095 |
02:58 ET | 8081 | 124.93 |
03:00 ET | 7797 | 124.97 |
03:02 ET | 30455 | 124.95 |
03:03 ET | 8300 | 125.085 |
03:05 ET | 7095 | 124.53 |
03:07 ET | 10203 | 124.66 |
03:09 ET | 6245 | 124.94 |
03:12 ET | 14529 | 124.96 |
03:14 ET | 10306 | 124.855 |
03:16 ET | 12202 | 124.6723 |
03:18 ET | 18704 | 124.2301 |
03:20 ET | 19007 | 123.92 |
03:21 ET | 19958 | 123.83 |
03:23 ET | 44543 | 124.11 |
03:25 ET | 19215 | 123.78 |
03:27 ET | 16626 | 123.758 |
03:30 ET | 20068 | 124.16 |
03:32 ET | 26151 | 123.7501 |
03:34 ET | 39201 | 123.65 |
03:36 ET | 36678 | 123.355 |
03:38 ET | 25136 | 123.225 |
03:39 ET | 20710 | 123.09 |
03:41 ET | 70131 | 123.24 |
03:43 ET | 41250 | 122.72 |
03:45 ET | 99214 | 123.24 |
03:48 ET | 35881 | 123.246 |
03:50 ET | 34862 | 122.75 |
03:52 ET | 44929 | 122.8 |
03:54 ET | 51772 | 122.805 |
03:56 ET | 61280 | 122.25 |
03:57 ET | 71576 | 122.56 |
03:59 ET | 687276 | 122.45 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Moderna Inc | 52.7B | -7.8x | --- |
ICON PLC | 26.1B | 38.0x | +4.68% |
Biogen Inc | 32.5B | 28.0x | -18.14% |
Biontech SE | 20.1B | 161.9x | --- |
Grifols SA | 6.0B | 23.1x | --- |
Alnylam Pharmaceuticals Inc | 30.4B | -90.5x | --- |
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $52.7B |
---|---|
Revenue (TTM) | $5.2B |
Shares Outstanding | 383.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.68 |
EPS | $-15.66 |
Book Value | $36.27 |
P/E Ratio | -7.8x |
Price/Sales (TTM) | 10.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -99.73% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.